Nephrologists must capitalize on new therapeutic agents and opportunities to carry on the momentum of the field, according to Prabir Roy-Chaudhury, MD, PhD, FASN.Roy-Chaudhury, president of the ...

Continuous glucose monitoring can identify unrecognized hyperglycemia and hypoglycemia in dialysis patients, challenging ...

Kidney transplant recipients with active or high risk for antibody-mediated rejection reported transplant benefits but still experienced physical restrictions and psychological concerns, according to ...

In late-breaking presentations at the American Society of Nephrology Kidney Week meeting and simultaneously published in two ...

Concerns arise over IV cannula quality in Tamil Nadu hospitals, with incidents of breakage leaving fragments inside patients’ veins.

Although rare kidney diseases remain a significantly overlooked contributor to the global burden of CKD, things have begun to ...

Experts discuss how stress impacts hormonal balance and fertility in young adults, highlighting the need for lifestyle ...

The results of two large-scale studies demonstrate that sodium-glucose co-transporter 2 (SGLT2) inhibitors significantly reduce the risk of kidney disease progression, hospitalisation, and death in ...

Q3 2025 Earnings Call Transcript November 12, 2025 Humacyte, Inc. beats earnings expectations. Reported EPS is $-0.14, ...

According to reporting from Reuters, reviewers at the agency pointed to an inability to differentiate from placebo to justify rejecting the drug, but an FDA office director approved the drug anyway.

Defense Health Agency officials have launched an effort to bring back Medicare-eligible Tricare for Life military patients to their treatment facilities, the Pentagon’s top doctor said this week.